Pancreatic Cancer Vaccines With Amazing Results in Phase I

Pancreatic ductal adenocarcinoma is one of the most lethal cancers with a 5 year survival rate of less than 10%. mRNA designer/personalized vaccines are changing this situation. Let's review the results of phase I trials.

Want to get access to DrBeen at low price of $4.99/month? Click here: https://www.drbeen.com/mednerd/

Want to support this work?:
Buy me a coffee :) https://www.buymeacoffee.com/DrMobeen...
Become my patron: https://www.patreon.com/mobeensyed?fa...
PayPal: https://paypal.me/mobeensyed?locale.x...

My substack: https://mobeensyedmd.substack.com/

#drbeen #koolbeens #HealthPolicy

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.


URL list from Tuesday, Jun. 4 2024 11:37 AM

Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
https://rojournal.biomedcentral.com/...

NHS England Thousands of NHS patients to access trials of personalised cancer ‘vaccines’
https://www.england.nhs.uk/2024/05/th...


Threeyear Phase 1 FollowUp Data for mRNAbased Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer | BioNTech
https://investors.biontech.de/newsre...

Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer | Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/news/canmrnav...

Trial Design
https://www.biontech.com/int/en/home/...

Cancer vaccines are having a renaissance | MIT Technology Review
https://www.technologyreview.com/2024...

NHS England launches scheme to boost signups for personalised cancer vaccine trials | The BMJ
https://www.bmj.com/content/385/bmj.q....